As 2026 begins, a slate of high-stakes clinical readouts—from a pivotal study of Novartis’ cardiovascular candidate ...
A Kentucky toddler is finished with the fourth phase of aggressive chemotherapy, and the family updates LEX18 on his journey.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback